O'Donnell Niall (CIK 0001780235)

Latest company ownership

Shares held
1,621,118
Last filed at
Nov 15, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
30,000
Last filed at
May 26, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
17,500
Last filed at
Jun 8, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 16, 2023 May 16, 2023 SPRUCE BIOSCIENCES, INC. Director Buy 100.0 +630,400 90.59% ✗ $2M
May 8, 2023 May 10, 2023 OnKure Therapeutics, Inc. Director Buy 95.0 +125,000 6.06% ✗ $1M
Nov 11, 2022 Nov 15, 2022 Mirum Pharmaceuticals, Inc. Director Sell 16.3 -300,000 -15.62% ✗ $6M
Apr 13, 2021 Apr 15, 2021 OnKure Therapeutics, Inc. Director Buy 100.0 +200,000 10.73% ✗ $3M
Oct 14, 2020 Oct 16, 2020 SPRUCE BIOSCIENCES, INC. Director Buy 100.0 +250,000 56.07% ✗ $3.8M
Jul 22, 2019 Jul 24, 2019 Mirum Pharmaceuticals, Inc. Director Buy 100.0 +300,000 18.51% ✗ $4.5M